KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Gross Profit (2016 - 2025)

Historic Gross Profit for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Cme's Gross Profit fell 260.17% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 billion, marking a year-over-year increase of 657.76%. This contributed to the annual value of $5.9 billion for FY2024, which is 1055.48% up from last year.
  • Cme's Gross Profit amounted to $1.5 billion in Q3 2025, which was down 260.17% from $1.6 billion recorded in Q2 2025.
  • Cme's Gross Profit's 5-year high stood at $1.6 billion during Q2 2025, with a 5-year trough of $1.1 billion in Q3 2021.
  • Over the past 5 years, Cme's median Gross Profit value was $1.3 billion (recorded in 2023), while the average stood at $1.3 billion.
  • In the last 5 years, Cme's Gross Profit plummeted by 1695.42% in 2021 and then soared by 2018.33% in 2023.
  • Quarter analysis of 5 years shows Cme's Gross Profit stood at $1.1 billion in 2021, then rose by 4.35% to $1.1 billion in 2022, then grew by 20.18% to $1.3 billion in 2023, then grew by 7.29% to $1.4 billion in 2024, then rose by 3.32% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.6 billion for Q2 2025, and $1.6 billion during Q1 2025.